POST PARTUM PREGNANCY INDUCED HYPERTENSION Group A3 Aramburo Guanzon Capino Largo Chan Paguirigan Diron Rosadia Fajardo Sonico Vargas
Feb 03, 2016
POST PARTUM
PREGNANCY INDUCED
HYPERTENSION Group A3
Aramburo Guanzon
Capino Largo
Chan Paguirigan
Diron Rosadia
Fajardo Sonico
Vargas
INTRODUCTION
WHAT IS PREECLMAPSIA
OBJECTIVE OF THE
STUDY
This case study was designed to
complement the gained knowledge
from our experiences, peers and
clinical instructors. It will serve as
the backbone of our specific
studies, rather than serve as a
stand – alone sharing tool for our
knowledge.
The primary goal of this case study
was to expand our experienced
and learned knowledge and
discover rationales behind every
procedure, terms and even roots of
our chosen OB – WARD case.
SIGNIFICANCE OF STUDY
For the students:
•Students who will be reading
this case study will become
aware of the nursing
management as well as
pathophysiology of post partum
preeclampsia
For the clinical instructor
Clinical instructors that will view
this will have a better idea and
understanding of how students
understand cases assigned to them
and help add information onto their
learned experiences and
knowledge
For the faculty:
To display excellent understanding of
what we have learned, what we have
accomplished and what we strived to
understand while under the OB –
WARD. Also, this case study signifies
the importance of knowledge and
research to our daily activities as a
student nurse
PATIENT’S PROFILE
Biographical Data
Patient’s Name: M.D.R
Birthday: May 16, 1974
Birthplace: Quezon City
Age: 40 years old
Sex: Female
Present Place of Residence: #6 C6-A R.M.A Kalusya
St. Tatalon. Quezon City
Nationality: Filipino
Religion: Catholic
Languages/ Dialect Spoken: Tagalog
Marital Status History: Married
Occupation and Employment History: Housewife
Local or Foreign Travel (if any) : none
Sleep habits/ pattern: Irregular
Sleeping Time: 7am
Waking Time: 1pm
Handedness: Right
Eye Glasses: N/A
Reason for Glasses: N/A
Contact Lenses: N/A
Hearing Aid: N/A
Dentures: N/A
Dietary Habits/ Eating Pattern: 3 x a day and snacks
Particular Food Preference: gulay, gata and chopsuey
Exercise: Walking
Frequency/Week: 2 x a week
Duration: 15 mins
Alcohol/ Caffeine (Amount/Duration): none
Tobacco/ Drug Abuse (Amount/Duration): none
Living Environment: ( Type of house, No. of
Occupants, and Community Setting): Living with
parents
Source of Income: Husband
Current Medication: Celecoxin 200 mg 1tab (BID)
Cefuroxime (Elixime) 500mg/tab
(BID)
Irbesatran 150mg/tab Ob in PM
Wifedipine 30mg/tab Ob in AM
ADMISSION DATE: July 08, 2014
Obstetric History:
Menarche: at age of 13
AOG: 39 6/7 weeks
EDD: 08/20/14
Baby born: 07/08/14
Surgeries: had C.S last 2002
G2T1P1A0L2M0
Diagnostic results:
•+1 protenuria
(urinalysis)
•+ Edema- U.E and L.E
Medical Diagnosis
(Admitting diagnosis)Previous as for
non measuring fetal status, pre
eclampsia
(Final Diagnosis) Pregnancy Uterine
operative delivery via Emergency in
transverse Cervical Cesarean section
II for repeat E severe pre eclampsia
delivered a LFT boy
Nursing Diagnosis
Risk for injury
related to elevated
blood pressure
PAST HISTORY OF
ILLNESS
General Health: Relatively Good
Accidents or Injuries: None
Childhood Illness: None
Hospitalization: First time on this
case
PRESENT HEALTH
HISTORY
•The patient is a 40 year old G2P1 (1001), 36 3/7 weeks AOG by LMP.
•Last menstrual period (LMP) on October 13 2013. Patient went to the OB-GYNE OPD.
•Her last PNCU was on July 1 2014.
• She experienced many subjective
complaint such as dizziness.
• On the day of admission, patient went to
UERM for B.P examination. BP was
200/100 to 180/90. 160/80.
• After that Patient had her urinalysis and
with result with Protenuria. Then she was
advised for admission
B – There is tenderness in the breast.
U – Contracted
B – Not distended
B – Bowel sounds RLQ – 8 LUQ - 10
RUQ – 10 LLQ – 6
L – No lochia
E – Cesarian
S – 8:45am BP: 140/90 PR PR: 79
RR: 18 Temperature: 36.5°C
H – No homan signs (Negative Homan sign)
E – The client wished to be discharge as soon as possible
FAMILY HISTORY
HT HT
PHYSICAL ASSESSMENT
PATHOPHYSIOLOGY
NURSING CARE PLANS
NURSING MANAGEMENT
DRUG ANALYSIS
IRBESATRAN 150MG/TAB
OB IN PM (Administered drug)
CELECOXIN 200 MG 1TAB
(BID) (Administered drug)
CEFUROXIME (ELIXIME)
500MG/TAB (BID) (Administered drug)
NIFEDIPINE 30MG/TAB OB
IN AM (Administered drug)
Prescribed for:
Nifedipine is used for the treatment and
prevention of angina resulting from either an
increased workload on the heart (as with
exercise) or spasm of the coronary arteries.
It is used in the treatment of high blood
pressure, to treat abnormally fast heart
rhythms such as atrial fibrillation, and in the
prevention of episodes of rapid heart rhythm
originating from the atria of the heart.
•It also is used to dilate blood
vessels that go into spasm such
as those causing Raynaud's
phenomenon, a painful condition
of the hands caused by spasm of
the arteries supplying blood to the
hands.
MAGNESIUM SULFATE (Ideal Prescription drug)
AMLODIPINE 10 MG (Ideal Situational Drug)
Prescribed for:
• Chest pain or heart pain (angina) occurs because of
insufficient oxygen delivered to the heart muscles.
Insufficient oxygen may be a result of coronary artery
blockage or spasm, or because of exertion which
increases the need of the heart for oxygen in patients with
coronary artery narrowing (coronary artery disease or
atherosclerosis).
• Amlodipine is used for the treatment and prevention of
angina resulting from coronary spasm as well as from
exertion.
• Amlodipine also is used in the treatment of high blood
pressure.
Dosing
• The recommended starting dose of
amlodipine for children and adults is 2.5 to
5 mg once daily.
• The maximum dose for adults is 10 mg
once daily and the maximum dose for
children is 5 mg once daily.
• Amlodipine can be taken with or without
food. Amlodipine is inactivated mainly by
the liver, and dosages may need to be
lowered in patients with liver dysfunction.
Side Effects:
•Side effects of amlodipine are
generally mild and reversible. The two
most common side effects
are headache and edema(swelling) of
the lower extremities.
•Less common side effects include
dizziness, flushing, fatigue, nausea,
and palpitations.
FIN